According to the Summary of Product Characteristics (SmPCs), GLP-1 medications commonly cause nausea (reported in approximately 20-40% of patients with semaglutide and 12-21% with dulaglutide), vomiting, and diarrhoea, particularly during initial treatment and dose escalation
Moreover, establishing optimal fasting protocols and evaluating long-term safety across various populations will be crucial for enhancing clinical guidelines and optimizing therapeutic efficacy
O ritmo dessas apreenses, feitas pela Receita Federal e pela Anvisa na fronteira de Foz do Iguau, cresceu to rpido que o valor retido s nos trs primeiros meses de 2026 mais de R$ 11 milhes j supera o total apreendido em todo o ano de 2025
What GLOW Can Do for You Firmer, Younger Skin GHK-Cu stimulates collagen and elastin at the cellular level, improving skin firmness, texture, and tone